好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | S15 - Innovations in Alzheimer's Diagnostics

Monday 04/07/25
01:00 PM - 03:00 PM PDT Add To Calendar
San Diego Convention Center | 25C
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Claire E. Delpirou Nouh, MD, Lealani M. Acosta, MD, MPH, FAAN
Aging, Dementia, and Behavioral Neurology
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:12 PM PDT Speaker 2025 Norman Geschwind Prize in Behavioral Neurology: This prize is awarded to an individual for outstanding research in the field of behavioral neurology
Matthew J. Burke, MD, FRCPC
01:12 PM - 01:24 PM PDT Abstract 002 - Glymphatic System Dysfunction Predicts Amyloid Deposition, Neurodegeneration, and Clinical Progression in Alzheimer’s Disease
Shuyi Huang, MD, PhD
01:24 PM - 01:36 PM PDT Abstract 003 - Cross-Trial Knowledge Transfer in Alzheimer's Disease: A Machine Learning Approach Using the EXPEDITION Trials
Ali Ezzati, MD
01:36 PM - 01:48 PM PDT Abstract 004 - Combination of Plasma Beta Amyloid 42/40 and P-tau217 in the Assessment of Alzheimer's Disease
Michael K. Racke, MD
01:48 PM - 02:00 PM PDT Abstract 005 - Performance of Alzheimer Disease Plasma Biomarkers in a Specialty Memory Clinic
Yoav Piura, MD
02:00 PM - 02:12 PM PDT Abstract 006 - Influence of Cognitive Impairment and Race on Plasma P-Tau217 in Two Diverse Cohorts
William T. Hu, MD, PhD, FAAN
02:12 PM - 02:24 PM PDT Abstract 007 - Graphical Model Analysis of Global Amyloid's Impact on Regional Tau Dynamics
Krish B. Kapadia, BS
02:24 PM - 02:36 PM PDT Abstract 008 - ALTITUDE-AD: Use of a Validated Plasma pTau217 Assay to Screen Potential Participants in an Ongoing Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Sabirnetug for Early Alzheimer's Disease
todd feaster, PsyD
02:36 PM - 02:48 PM PDT Abstract 009 - Associations Between Cardiometabolic Multimorbidity and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Adults: the CABLE Study
Qiongyao Li, PhD
02:48 PM - 03:00 PM PDT Abstract 010 - Sleep Quality, APOE e4, and Alzheimer’s Disease: Cohort Studies and Plasma Proteomics
Liangyu Huang, MD, PhD
Faculty Disclosures
Claire E. Delpirou Nouh, MD Dr. Delpirou Nouh has a non-compensated relationship as a Volunteer/Board member with Oklahoma Alzheimer Association that is relevant to AAN interests or activities.
Matthew J. Burke, MD, FRCPC Dr. Burke has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Burn Tucker Lachaîne. Dr. Burke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Lerners LLP. Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Blakes LLP. Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Carroll Heyd Chown LLP. Dr. Burke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Caza Saikaley LLP. The institution of Dr. Burke has received research support from Liu Fu Yu Charity Foundation.
Yoav Piura, MD Dr. Piura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Piura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parabon Nanolabs. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Christian Lachner Christian Lachner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerView.
Alicia Algeciras-Schimnich Alicia Algeciras-Schimnich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Alicia Algeciras-Schimnich has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fujirebio Diagnostics. Alicia Algeciras-Schimnich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics.
Daniel Figdore Daniel Figdore has nothing to disclose.
Joshua Bornhorst, PhD Prof. Bornhorst has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roiche.
Shuyi Huang, MD, PhD Dr. Huang has nothing to disclose.
Jintai Yu No disclosure on file
Krish B. Kapadia, BS Mr. Kapadia has nothing to disclose.
Meagan Lauber Ms. Lauber has nothing to disclose.
Matteo Bellitti, PhD The institution of Dr. Bellitti has received research support from Framingham Heart Study Brain Aging Program. The institution of Dr. Bellitti has received research support from National Institutes of Health. The institution of Dr. Bellitti has received research support from American Heart Association.
Varuna Jasodanand Miss Jasodanand has nothing to disclose.
Vijaya B. Kolachalama, PhD, FAHA Vijaya B. Kolachalama, PhD, FAHA has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Vijaya B. Kolachalama, PhD, FAHA has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Altoida. Vijaya B. Kolachalama, PhD, FAHA has stock in CogniScreen Inc.. Vijaya B. Kolachalama, PhD, FAHA has stock in deepPath Inc..
Karen Sundell Karen Sundell has received personal compensation for serving as an employee of Acumen Pharmaceuticals . Karen Sundell has stock in Acumen Pharmaceuticals .
Maddelyn Hyland, MPH Miss Hyland has received personal compensation for serving as an employee of Acumen Pharmaceuticals.
Gopalan Sethuraman Dr. Sethuraman has received personal compensation for serving as an employee of Acumen Pharmaceuticals. Dr. Sethuraman has stock in Acumen Pharmaceuticals.
Vlad Skljarevski, MD The institution of Dr. Skljarevski has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Acumen Pharmaceuticals.
june kaplow, PhD Dr. kaplow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Acumen Pharmaceuticals Inc.
Robert A. Dean Robert A. Dean has received personal compensation for serving as an employee of Acumen Pharmaceutics. Robert A. Dean has received personal compensation for serving as an employee of Gates Ventures. Robert A. Dean has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Robert A Dean Consulting, LLC. Robert A. Dean has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Jasna Jerecic, PhD Dr. Jerecic has received personal compensation for serving as an employee of Acumen Pharmaceuticals Inc.
Eric R. Siemers, MD Dr. Siemers has received personal compensation for serving as an employee of Acumen Pharmaceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Vaccinex Pharmceuticals. The institution of Dr. Siemers has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cogstate Ltd. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Gates Ventures LLC. The institution of Dr. Siemers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for US Green Valley Pharmaceuticals, Inc. Dr. Siemers has stock in Acumen Pharmaceuticals. Dr. Siemers has stock in Ell Lilly and Company. Dr. Siemers has received personal compensation in the range of $0-$499 for serving as a study section reviewer with National Institutes of Health. Dr. Siemers has a non-compensated relationship as a Volunteer with Alzheimer's Association that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Bright Focus Foundation that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Huntington Study Group that is relevant to AAN interests or activities.
todd feaster, PsyD Dr. feaster has received personal compensation for serving as an employee of Acumen Pharmaceuticals. Dr. feaster has stock in Acumen Pharmaceuticals.
Michael K. Racke, MD Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has stock in Quest Diagnostics. Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Darren Weber Mr. Weber has received personal compensation for serving as an employee of Quest Diagnostics.
Matthew Stroh, PhD Dr. Stroh has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Stroh has stock in Quest Diagnostics.
Jesse DeSimone, PhD Dr. DeSimone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Automated Imaging Diagnostics, LLC.
Stephen Coombes, PhD Dr. Coombes has received personal compensation in the range of $10,000-$49,999 for serving as a partner with Neuroimaging Solutions LLC.
Sruti Rayaprolu, PhD Mrs. Rayaprolu has nothing to disclose.
Wei-en Wang, PhD Dr. Wang has nothing to disclose.
Rosie E. Curiel Cid, PsyD No disclosure on file
Melissa Armstrong, MD, MSc, FAAN, FAAN The institution of Dr. Armstrong has received research support from National Institute of Aging. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. Dr. Armstrong has received research support from Parkinson Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
David Loewenstein, PhD Dr. Loewenstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ifunction. The institution of Dr. Loewenstein has received research support from National Institutes of Health.
Glenn Smith, PhD The institution of Prof. Smith has received research support from NIH. Prof. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a expert panelist with Alzheimers Association Project Echo.
Ranjan Duara, MD Dr. Duara has nothing to disclose.
David Vaillancourt David Vaillancourt has received personal compensation for serving as an employee of Automated Imaging Diagnostics. David Vaillancourt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of David Vaillancourt has received research support from NIH. David Vaillancourt has received intellectual property interests from a discovery or technology relating to health care.
Steven W. Taylor, PhD Dr. Taylor has received personal compensation for serving as an employee of Quest Diagnostics.
Judy Louie, MS Mrs. Louie has received personal compensation for serving as an employee of Quest Diagnostics.
William T. Hu, MD, PhD, FAAN Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics.
Elham Ghanbarian, MD, PhD Dr. Ghanbarian has nothing to disclose.
Ali Ezzati, MD The institution of Dr. Ezzati has received research support from NIA. The institution of Dr. Ezzati has received research support from Alzheimer's Association. The institution of Dr. Ezzati has received research support from Cure Alzheimer's Fund.
Babak Khorsand, PhD Dr. Khorsand has nothing to disclose.
Bhargav Nallapu Bhargav Nallapu has nothing to disclose.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Qiongyao Li, PhD Ms. Li has nothing to disclose.
Liangyu Huang, MD, PhD Dr. Huang has nothing to disclose.
Lealani M. Acosta, MD, MPH, FAAN Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences.
Jin-Tai Yu, PhD Prof. Yu has nothing to disclose.